6505--Eszopiclone Tablets
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79725R0070
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The VA National Acquisition Center intends to issue Request for Proposal 36E79725R0070 for an unrestricted procurement of Eszopiclone Tablets to serve multiple federal agencies including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The procurement seeks a single contractor capable of providing an uninterrupted supply of Eszopiclone Tablets in three strengths (1mg, 2mg, and 3mg) packaged in 30-count bottles with specific safety-cap and packaging requirements. Offerors must provide a unique NDC number and use only their own labeling without affixing labels over existing ones, with products distributed through VA and DoD Pharmaceutical Prime Vendor Programs. The contract will be structured as a one-year base period with four pre-priced one-year option periods, totaling up to five years. The solicitation will be electronically issued on October 23, 2025, following commercial item format per FAR Part 12, with proposals due November 6, 2025 at 2:30 PM Central Time.
This procurement does not utilize any set-aside designations and is open to all qualified contractors. The estimated annual usage requirements are substantial, with 39,279 bottles needed for 1mg strength, 69,052 bottles for 2mg strength, and 119,905 bottles for 3mg strength, representing a total annual demand of approximately 228,236 bottles across all three tablet strengths. All unit-of-use packaging must meet stringent specifications including 30-count bottles with 120cc minimum volume, cylindrical bodies with minimum 5.75-inch circumference, and compatibility with 5.25" x 2" labels while maintaining safety-cap functionality. The contract structure spans a potential five-year period through the base year plus four option years, ensuring long-term pharmaceutical supply continuity across multiple federal healthcare systems. No incumbent contractor or current suppliers are identified in the presolicitation notice, nor are specific award values or budget ranges disclosed.
Notice text
Presolicitation Notice
Presolicitation Notice
Page 3 of 3
Presolicitation Notice
*=Required Field
Presolicitation Notice
Page 1 of 3
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0070 for an unrestricted procurement for Eszopiclone Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 3, 30 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.
Solicitation # 36E79725R0070 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 23, 2025, with a tentative closing date of November 6, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Richard Mahario. Questions can be e-mailed to Richard.Mahario@va.gov Richard.Mahario@va.gov.
The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION
ITEM
DESCRIPTION
PACKAGE SIZE (Tablets per Bottle)
TOTAL ESTIMATED ANNUAL USAGE (Bottles)
1
Eszopiclone 1MG Tablets
30
39,279
2
Eszopiclone 2MG Tablets
30
69,052
3
Eszopiclone 3MG Tablets
30
119,905
Files
| File | Type | Posted |
|---|---|---|
| 36E79725R0070_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Eszopiclone Tablets - Golden State Medical Supply, Inc. | Award Notice | |
| 6505--Eszopiclone Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity